Innovative Payment Solutions, Inc. - IPSI

IPSI Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
IPSI	-17.8	-62.0	-89.1	-94	-97.4	-97.5	-99.2	364499900	-98.4	-98.4
S&P 500	0.4	-0.2	3.0	1.8	17.0	21.8	35.7	82.8	197.2	34348.3

Compare IPSI with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	IPSI
name	Innovative Payment Solutions, Inc.
price	0.006
changes percentage	-17.8082
change	-0.0013
day low	0.006
day high	0.0075
year high	0.346
year low	0.006
market cap	112388
price avg 50	0.05548
price avg 200	0.127595
exchange	PNK
volume	1881365
avg volume	270888
open	0.0075
previous close	0.0073
eps	-0.33
pe	-0.02
earnings announcement	2025-03-27T16:48:00.000+0000
shares outstanding	18731400
timestamp	2025-02-06 20:46:29

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 40.3%

Overall Quarterly Financial Health: 11.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001591913
revenue	410	847	-51.59
gross profit	-3137	-4205	25.40
gross profit ratio	-7.65	-4.96	-54.12
research and development expenses	347298	100909	244.17
operating expenses	3956986	5673273	-30.25
interest income	0	462988	-100.00
interest expense	1194489	462988	158.00
ebitda	-3322707	-9546833	65.20
ebitdaratio	-8104.16	-11980.87	32.36
operating income	-3960123	-5677478	30.25
operating income ratio	-9658.84	-6703.04	-44.10
net income	-5835760	-9876406	40.91
net income ratio	-14233.56	-11660.46	-22.07
eps	-0.45	-0.8	43.75

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 0 million in 2023 from 0 million in 2022 representing a change of -51.59%. This indicates a sales shrinking, which is a negative sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -3 million in 2023 from -10 million in 2022 representing a change of 65.2%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to -4 million in 2023 from -6 million in 2022 representing a change of 30.25%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -6 million in 2023 from -10 million in 2022 representing a change of 40.91%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 0 million in 2023 from 0 million in 2022 representing a change of 25.4%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 0 million in 2023 from 0 million in 2022 representing a change of 244.17%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 4 million in 2023 from 6 million in 2022 representing a change of -30.25%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Earnings per Share (EPS): EPS increased to -0.45 in 2023 from -0.45 in 2022 representing a change of 43.75%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001591913
revenue	0	0	NaN
gross profit	0	-542.0	100.00
gross profit ratio	0	0	NaN
research and development expenses	0	0	NaN
operating expenses	296438	407132	-27.19
interest income	9740	7997	21.80
interest expense	386324	466522	-17.19
ebitda	-1341197	-330493	-305.82
ebitdaratio	0	0	NaN
operating income	-296981	-407674	27.15
operating income ratio	0	0	NaN
net income	-1728152	-797645	-116.66
net income ratio	0	0	NaN
eps	-0.15	-0.06	-159.97

Overall Score of Quarterly Income Statement

None

Detailed Analysis

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001591913
total assets	805216	2752572	-70.75
total liabilities	8383227	6707222	24.99
total equity	-7578011	-3954650	-91.62
cash and cash equivalents	50433	374765	-86.54
short term investments	0	0	NaN
long term investments	703938	500000	40.79
total current assets	89251	471807	-81.08
total non current assets	715965	2280765	-68.61
total current liabilities	8233226	6543244	25.83
total non current liabilities	150000	163978	-8.52
common stock	1382	37690	-96.33
retained earnings	-58235618	-52399858	-11.14
total debt	4925656	3394848	45.09

Overall Score of Annual Balance Sheet

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 1 million in 2023 from 3 million in 2022 representing a change of -70.75%. Suggesting a decrease in asset holdings.

  Total Liabilities: Total Liabilities increased to 8 million in 2023 from 7 million in 2022 representing a change of 24.99%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to -8 million in 2023 from -4 million in 2022 representing a change of -91.62%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 0 million in 2023 from 0 million in 2022 representing a change of -86.54%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 0 million in 2023 from 0 million in 2022 representing a change of -81.08%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 8 million in 2023 from 7 million in 2022 representing a change of 25.83%. This indicates a higher short-term debt burden.

  Common Stock: Common Stock decreased to 0 in 2023 from 0 in 2022 representing a change of -96.33%. This indicates a decrease in ownership interest.

  Retained Earnings: Retained Earnings decreased to -58 million in 2023 from -52 million in 2022 representing a change of -11.14%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 5 million in 2023 from 3 million in 2022 representing a change of 45.09%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001591913
total assets	1037752	1011898	2.56
total liabilities	10629015	9267649	14.69
total equity	-9591263	-8255751	-16.18
cash and cash equivalents	1033	79027	-98.69
short term investments	0	0	NaN
long term investments	703778	873406	-19.42
total current assets	145627	127550	14.17
total non current assets	892125	884347	0.88
total current liabilities	10479015	9117649	14.93
total non current liabilities	150000	150000	0.00
common stock	1619	1382	17.15
retained earnings	-61519687	-59364728	-3.63
total debt	6464721	6136841	5.34

Overall Score of Quarterly Balance Sheet

0.33 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1 million in 2024Q3 from 1 million in 2024Q2 representing a change of 2.56%. Suggesting a growth in asset holdings.

  Total Current Assets: Total Current Assets increased to 0 million in 2024Q3 from 0 million in 2024Q2 representing a change of 14.17%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 0 in 2024Q3 from 0 in 2024Q2 representing a change of 17.15%. This indicates an increase in ownership interest.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 11 million in 2024Q3 from 9 million in 2024Q2 representing a change of 14.69%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to -10 million in 2024Q3 from -8 million in 2024Q2 representing a change of -16.18%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 0 million in 2024Q3 from 0 million in 2024Q2 representing a change of -98.69%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 10 million in 2024Q3 from 9 million in 2024Q2 representing a change of 14.93%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to -62 million in 2024Q3 from -59 million in 2024Q2 representing a change of -3.63%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 6 million in 2024Q3 from 6 million in 2024Q2 representing a change of 5.34%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001591913
net change in cash	-324332	-5074986	93.61
operating cash flow	-1416809	-3061953	53.73
free cash flow	-1461214	-3924784	62.77
capital expenditure	-44405	-862831	94.85
depreciation and amortization	380634	132394	187.50
deferred income tax	0	0	NaN
stock based compensation	377856	1594746	-76.31
accounts payables	1577888	296528	432.12
inventory	0	-296528	100.00
acquisitions net	-984200	9653.0	-10295.79
investments in property plant and equipment	-44405	-862831	94.85
net cash used for investing activites	-1064835	-875623	-21.61
debt repayment	2157312	-1147063	288.07
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	2157312	-1137410	289.67
cash at end of period	50433	374765	-86.54
accounts receivables	0	296528	-100.00
cash at beginning of period	374765	5449751	-93.12

Overall Score of Annual Cashflow Statement

0.71 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 0 million in 2023 from -5 million in 2022 representing a change of 93.61%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to -1 million in 2023 from -3 million in 2022 representing a change of 53.73%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to -1 million in 2023 from -4 million in 2022 representing a change of 62.77%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2023 from 2 million in 2022 representing a change of -76.31%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Receivables: Accounts Receivables decreased to 0 million in 2023 from 0 million in 2022 representing a change of -100.0%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to 0 million in 2023 from -1 million in 2022 representing a change of 94.85%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 2 million in 2023 from 0 million in 2022 representing a change of 432.12%. This indicates that the company has increased its outstanding obligations to its suppliers.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001591913
operating cash flow	-117451	-160646	26.89
free cash flow	-117451	-160646	26.89
capital expenditure	1.63	-1.63	200.00
depreciation and amortization	543.0	542	0.18
deferred income tax	0	0	NaN
stock based compensation	31488	94464	-66.67
accounts receivables	0	0	NaN
accounts payables	145089	143048	1.43
inventory	0	0	NaN
acquisitions net	500	0	NaN
investments in property plant and equipment	1.63	-1.63	200.00
net cash used for investing activites	-100000	-28603	-249.61
debt repayment	0	258502	-100.00
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	139457	258502	-46.05
net change in cash	-77994	72152	-208.10
cash at end of period	1033	79027	-98.69
cash at beginning of period	79027	6875	1049.48

Overall Score of Quarterly Cashflow Statement

None

Detailed Analysis

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	0.0	0.0	-53.24
net income per share	-0.45	-0.8	42.93
operating cash flow per share	-0.11	-0.25	55.31
free cash flow per share	-0.11	-0.32	64.04
cash per share	0.0	0.03	-87.00
book value per share	-0.59	-0.32	-85.09
tangible book value per share	-0.59	-0.46	-29.61
shareholders equity per share	-0.59	-0.32	-85.01
interest debt per share	0.48	0.31	53.23
market cap	3387765.62	4359081.75	-22.28
enterprise value	8262988.62	7379164.75	11.98
pe ratio	-0.58	-0.44	-31.53
price to sales ratio	8262.84	5146.5	60.55
pocfratio	-2.39	-1.42	-67.96
pfcf ratio	-2.32	-1.11	-108.75
pb ratio	-0.45	-1.1	59.43
ptb ratio	-0.45	-1.1	59.43
ev to sales	20153.63	8712.12	131.33
enterprise value over ebitda	-2.49	-0.77	-221.73
ev to operating cash flow	-5.83	-2.41	-142.00
ev to free cash flow	-5.65	-1.88	-200.77
earnings yield	-1.72	-2.27	23.97
free cash flow yield	-0.43	-0.9	52.10
debt to equity	-0.65	-0.86	24.25
debt to assets	6.12	1.23	395.99
net debt to ebitda	-1.47	-0.32	-363.81
current ratio	0.01	0.07	-84.97
interest coverage	-3.32	-12.26	72.96
income quality	0.27	0.3	-9.82
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	8722.81	6541.77	33.34
research and ddevelopement to revenue	847.07	119.14	611.00
intangibles to total assets	0	0.61	-100.00
capex to operating cash flow	-0.03	-0.28	88.88
capex to revenue	108.3	1018.69	-89.37
capex to depreciation	0.12	6.52	-98.21
stock based compensation to revenue	921.6	1882.82	-51.05
graham number	2.46	2.39	2.76
roic	1.62	9.7	-83.33
return on tangible assets	-7.25	-9.32	22.23
graham net net	-0.65	-0.51	-27.10
working capital	-8143975	-6071437	-34.14
tangible asset value	-7578011	-5647461	-34.18
net current asset value	-8293976	-6235415	-33.01
invested capital	-8136948	-4338264	-87.56
average receivables	0	0	NaN
average payables	1375648.5	596563.5	130.60
average inventory	0	0	NaN
days sales outstanding	0	0	NaN
days payables outstanding	208213.1	52591.36	295.91
days of inventory on hand	0	0	NaN
receivables turnover	0	0	NaN
payables turnover	0.0	0.01	-74.74
inventory turnover	0	0	NaN
roe	0.77	2.5	-69.15
capex per share	0.0	0.07	-95.03

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.77 on 2023-12-31 from 2.50 on 2022-12-31, representing a change of -69.15%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to -0.65 on 2023-12-31 from -0.86 on 2022-12-31, representing a change of 24.25%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -0.58 on 2023-12-31 from -0.44 on 2022-12-31, representing a change of -31.53%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio decreased to 0.01 on 2023-12-31 from 0.07 on 2022-12-31, representing a change of -84.97%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
IPSI
calendar year	2024	2024	NaN
revenue per share	0	0	NaN
net income per share	-0.12	-0.06	-105.84
operating cash flow per share	-0.01	-0.01	30.54
free cash flow per share	-0.01	-0.01	30.54
cash per share	0.0	0.01	-98.76
book value per share	-0.66	-0.6	-10.38
tangible book value per share	-0.66	-0.6	-10.38
shareholders equity per share	-0.66	-0.6	-10.38
interest debt per share	0.47	0.48	-1.43
market cap	1236415.1	1865685.02	-33.73
enterprise value	7700103.1	7923499.02	-2.82
pe ratio	-0.18	-0.58	69.41
price to sales ratio	0	0	NaN
pocfratio	-10.53	-11.61	9.36
pfcf ratio	-10.53	-11.61	9.36
pb ratio	-0.13	-0.23	42.96
ptb ratio	-0.13	-0.23	42.96
ev to sales	0	0	NaN
enterprise value over ebitda	-5.74	-23.97	76.05
ev to operating cash flow	-65.56	-49.32	-32.92
ev to free cash flow	-65.56	-49.32	-32.92
earnings yield	-1.4	-0.43	-226.92
free cash flow yield	-0.09	-0.09	-10.32
debt to equity	-0.67	-0.74	9.33
debt to assets	6.23	6.06	2.72
net debt to ebitda	-4.82	-18.33	73.71
current ratio	0.01	0.01	-0.66
interest coverage	-0.77	-0.87	12.03
income quality	0.07	0.2	-66.25
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0	0	NaN
capex to operating cash flow	-0.0	-0.0	-36.78
capex to revenue	0	0	NaN
capex to depreciation	0.0	0.0	-0.18
stock based compensation to revenue	0	0	NaN
graham number	1.33	0.88	50.73
roic	0.09	0.19	-50.63
return on tangible assets	-1.67	-0.79	-111.26
graham net net	-0.72	-0.66	-9.14
working capital	-10333388	-8990099	-14.94
tangible asset value	-9591263	-8255751	-16.18
net current asset value	-10483388	-9140099	-14.70
invested capital	-10327988	-8984157	-14.96
average receivables	81588.5	15486	426.85
average payables	2522645.5	2378576.5	6.06
average inventory	0	0	NaN
days sales outstanding	0	0	NaN
days payables outstanding	0	406843.17	-100.00
days of inventory on hand	0	0	NaN
receivables turnover	0	0	NaN
payables turnover	0	0.0	-100.00
inventory turnover	0	0	NaN
roe	0.18	0.1	86.49
capex per share	0.0	0.0	-4.99

• Positive

  ROE: Return on Equity (ROE) increased to 0.18 on 2024-09-30 Q3 from 0.10 on 2024-06-30 Q2, representing a change of 86.49%. Suggesting the company has been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to -0.18 on 2024-09-30 Q3 from -0.58 on 2024-06-30 Q2, representing a change of 69.41%. Indicating an increase in the relative valuation of the company's stock.

• Negative

  Current Ratio: Current Ratio decreased to 0.01 on 2024-09-30 Q3 from 0.01 on 2024-06-30 Q2, representing a change of -0.66%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to -0.67 on 2024-09-30 Q3 from -0.74 on 2024-06-30 Q2, representing a change of 9.33%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None